MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) Expression by targeting Mitogen-activated protein Kinase 8

Journal of Biological Chemistry

Volumn 288, Issue 15, 2013, Pages 10361-10373

  Zhang, Nan ^a   Lin, Jun Kai ^a   Chen, Juan ^a   Liu, Xiong Fei ^a   Liu, Jia Li ^a   Luo, Hao Shu ^a   Li, Yue Qin ^a   Cui, Sheng ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN-RELEASING FACTORS; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN-ACTIVATED PROTEIN KINASE KINASE; NEGATIVE REGULATORS; OVER-EXPRESSION; PITUITARY GLAND; SIGNALING PATHWAYS; TRANSCRIPTION ACTIVITY;

BRAIN; MAMMALS;

ENZYMES;

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MICRORNA 375; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 8; NUCLEAR RECEPTOR NUR77; PROOPIOMELANOCORTIN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HYPOPHYSIS INTERMEDIATE LOBE; HYPOPHYSIS TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA BINDING; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CORTICOTROPIN-RELEASING HORMONE; FEMALE; GENE EXPRESSION REGULATION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 8; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PHOSPHORYLATION; PITUITARY GLAND; PITUITARY NEOPLASMS; PRO-OPIOMELANOCORTIN;

EID: 84876215422     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.425504     Document Type: Article

References (46)

1. Raymond, V., Lépine, J., Giguère, V., Lissitzky, J. C., Côté, J., and Labrie, F. (1981) Parallel stimulation of ACTH, β-LPH +-endorphin and α-MSH release by α-adrenergic agents in rat anterior pituitary cells in culture. Mol. Cell. Endocrinol. 22, 295-303
2. Bertagna, X. (1994) Proopiomelanocortin-derived peptides. Endocrinol. Metab. Clin. North Am. 23, 467-485
3. Stevens, A., and White, A. (2010) ACTH: cellular peptide hormone synthesis and secretory pathways. Results Probl. Cell Differ. 50, 63-84
4. Tsigos, C., and Chrousos, G. P. (2002) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53, 865-871
5. Heijnen, C. J., Zijlstra, J., Kavelaars, A., Croiset, G., and Ballieux, R. E. (1987) Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav. Immun. 1, 284-291
6. Getting, S. J., Gibbs, L., Clark, A. J., Flower, R. J., and Perretti, M. (1999) POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J. Immunol. 162, 7446-7453
7. Knight, R. M., Farah, J. M., Bishop, J. F., and O'Donohue, T. L. (1987) CRF and cAMP regulation of POMC gene expression in corticotrophic tumor cells. Peptides 8, 927-934
8. Lundblad, J. R., and Roberts, J. L. (1988) Regulation of proopiomelanocortin gene expression in pituitary. Endocr. Rev. 9, 135-158
9. Affolter, H. U., and Reisine, T. (1985) Corticotropin releasing factor increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells. J. Biol. Chem. 260, 15477-15481
10. Rivier, C., and Vale, W. (1983) Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305, 325-327
11. Litvin, Y., PasMantier, R., Fleischer, N., and Erlichman, J. (1984) Hormo-nal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin. J. Biol. Chem. 259, 10296-10302
12. Luini, A., Lewis, D., Guild, S., Corda, D., and Axelrod, J. (1985) Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 82, 8034-8038
13. Kovalovsky, D., Refojo, D., Liberman, A. C., Hochbaum, D., Pereda, M. P., Coso, O. A., Stalla, G. K., Holsboer, F., and Arzt, E. (2002) Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol. Endocrinol. 16, 1638-1651
14. Liu, J., Lin, C., Gleiberman, A., Ohgi, K. A., Herman, T., Huang, H. P., Tsai, M. J., and Rosenfeld, M. G. (2001) Tbx19, a tissue-selective regulator of POMC gene expression. Proc. Natl. Acad. Sci. U.S.A. 98, 8674-8679
15. Lamolet, B., Pulichino, A. M., Lamonerie, T., Gauthier, Y., Brue, T., Enjalbert, A., and Drouin, J. (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104, 849-859
16. Drouin, J., Maira, M., and Philips, A. (1998) Novel mechanism of action for Nur77 and antagonism by glucocorticoids: a convergent mechanism for CRH activation and glucocorticoid repression of POMC gene transcription. J. Steroid Biochem. Mol. Biol. 65, 59-63
17. Murphy, E. P., and Conneely, O. M. (1997) Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol. Endocrinol. 11, 39-47
18. Philips, A., Lesage, S., Gingras, R., Maira, M. H., Gauthier, Y., Hugo, P., and Drouin, J. (1997) Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 17, 5946-5951
19. Philips, A., Maira, M., Mullick, A., Chamberland, M., Lesage, S., Hugo, P., and Drouin, J. (1997) Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 17, 5952-5959
20. Maira M, M. C., Philips A, Drouin J (1999) Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol. 19, 7549-7557
21. Mao, Z. G., He, D. S., Zhou, J., Yao, B., Xiao, W. W., Chen, C. H., Zhu, Y. H., and Wang, H. J. (2010) Differential expression of microRNAs in GHsecreting pituitary adenomas. Diagn. Pathol. 5, 79
22. Zhang, Z., Florez, S., Gutierrez-Hartmann, A., Martin, J. F., and Amendt, B. A. (2010) MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression. J. Biol. Chem. 285, 34718-34728
23. Nemoto, T., Mano, A., and Shibasaki, T. (2012) Increased expression of miR-325-3p by urocortin 2 and its involvement in stress-induced suppression of LH secretion in rat pituitary. Am. J. Physiol. Endocrinol. Metab. 302, E781-787
24. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., and Stoffel, M. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230
25. El Ouaamari, A., Baroukh, N., Martens, G. A., Lebrun, P., Pipeleers, D., and van Obberghen, E. (2008) miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic ≲βατ∀-cells. Diabetes 57, 2708-2717
26. de Souza Rocha Simonini, P., Breiling, A., Gupta, N., Malekpour, M., Youns, M., Omranipour, R., Malekpour, F., Volinia, S., Croce, C. M., Najmabadi, H., Diederichs, S., Sahin, O., Mayer, D., Lyko, F., Hoheisel, J. D., and Riazalhosseini, Y. (2010) Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor α in breast cancer cells. Cancer Res. 70, 9175-9184
27. Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., and Stoffel, M. (2009) miR-375 maintains normal pancreatic α-and β-cell mass. Proc. Natl. Acad. Sci. U.S.A. 106, 5813-5818
28. Hatziapostolou, M., Polytarchou, C., Panutsopulos, D., Covic, L., and Tsichlis, P. N. (2008) Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration. Cancer Res. 68, 1851-1861
29. Makris, A., Patriotis, C., Bear, S. E., and Tsichlis, P. N. (1993) Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion. J. Virol. 67, 4283-4289
30. Patriotis, C., Makris, A., Bear, S. E., and Tsichlis, P. N. (1993) Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc. Natl. Acad. Sci. U.S.A. 90, 2251-2255
31. Patriotis, C., Makris, A., Chernoff, J., and Tsichlis, P. N. (1994) Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 91, 9755-9759
32. Ceci, J. D., Patriotis, C. P., Tsatsanis, C., Makris, A. M., Kovatch, R., Swing, D. A., Jenkins, N. A., Tsichlis, P. N., and Copeland, N. G. (1997) Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11, 688-700
33. Dermitzaki, E., Tsatsanis, C., Gravanis, A., and Margioris, A. N. (2012) The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis. J. Cell. Physiol. 227, 1861-1872
34. Obernosterer, G., Martinez, J., and Alenius, M. (2007) Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nature Protoc. 2, 1508-1514
35. Sei, C., Toneff, T., Aaron, W., and Hook, V. Y. (2002) Regulation of cellular -MSH and -endorphin during stimulated secretion from intermediate pituitary cells: involvement of aspartyl and cysteine proteases in the control of cellular levels of-MSH and-endorphin. Peptides 23, 1409-1418
36. Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., Barbisin, M., Xu, N. L., Mahuvakar, V. R., Andersen, M. R., Lao, K. Q., Livak, K. J., and Guegler, K. J. (2005) Real-time quantification of micro-RNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179
37. Krüger, J., and Rehmsmeier, M. (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 34, W451-454
38. Arzt, E., and Holsboer, F. (2006) CRF signaling: molecular specificity for drug targeting in the CNS. Trends Pharmacol. Sci. 27, 531-538
39. Rehmsmeier, M., Steffen, P., Hochsmann, M., and Giegerich, R. (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517
40. Gavrin, L. K., Green, N., Hu, Y., Janz, K., Kaila, N., Li, H. Q., Tam, S. Y., Thomason, J. R., Gopalsamy, A., Ciszewski, G., Cuozzo, J. W., Hall, J. P., Hsu, S., Telliez, J. B., and Lin, L. L. (2005) Inhibition of Tpl2 kinase and TNF-production with 1,7-naphthyridine-3-carbonitriles: synthesis and structure-activity relationships. Bioorg. Med. Chem. Lett. 15, 5288-5292
41. Becquet, D., Guillaumond, F., Bosler, O., and François-Bellan, A. M. (2001) Long-term variations of AP-1 composition after CRH stimulation: consequence on POMC gene regulation. Mol. Cell. Endocrinol. 175, 93-100
42. Bak, M., Silahtaroglu, A., Møller, M., Christensen, M., Rath, M. F., Skryabin, B., Tommerup, N., and Kauppinen, S. (2008) MicroRNA expression in the adult mouse central nervous system. RNA 14, 432-444
43. Rajewsky, N., and Socci, N. D. (2004) Computational identification of microRNA targets. Dev. Biol. 267, 529-535
44. Hjalt, T. A., Semina, E. V., Amendt, B. A., and Murray, J. C. (2000) The Pitx2 protein in mouse development. Dev. Dyn 218, 195-200
45. Reyes, R., Martínez, S., González, M., Tramu, G., and Bello, A. R. (2008) Origin of adenohypophysial lobes and cells from Rathke's pouch in Swiss albino mice. Proliferation and expression of Pitx 2 and Calbindin D28K in corticotropic and somatotropic cell differentiation. Anat Histol. Embryol. 37, 263-271
46. Schneeberger, M., Altirriba, J., García, A., Esteban, Y., Castaño, C., García-Lavandeira, M., Alvarez, C. V., Gomis, R., and Claret, M. (2012) Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurdegeneration and development of obesity. Mol. Metab., in press